ERAMET Project Advances Towards Impact at Face-to-Face Meeting in Catania
From 14-16 April, the ERAMET team gathered in Catania, Italy, for a productive face-to-face meeting, bringing together consortium members to review…
Dissemination
The latest news, publications and events from the ERAMET consortium.
From 14-16 April, the ERAMET team gathered in Catania, Italy, for a productive face-to-face meeting, bringing together consortium members to review…
We are pleased to announce our upcoming Open Day, which will take place on April 15 during the upcoming Face-to-Face meeting. The event will bring …
Assessment and Benchmarking of Model Informed Approaches in Drug Development for Hemoglobinopathies: A Review of Scientific Advices From January 20…
Advancing Paediatric Drug Development Through Optimised Study Design We are pleased to highlight a new scientific publication by Phanio Djokoto, no…
From 26 to 28 November, ERAMET stepped into the heart of the UK pharmacokinetics community at Warwick Conferences, where the annual PKUK meeting ga…
“Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies” is ERAMET’s newest publication appearing in Natur…
ERAMET Project partner, Fondazione per la ricerca Farmacologica Gianni Benzi Onlus, will host the XVII edition of the Foresight Training Course, ti…
ERAMET was proud to participate in PAGE 2025, held from June 3–6 at the Thessaloniki Concert Hall, where experts from across academia, regulatory a…
A new article has been published in Clinical and Translational Science, titled: AI-Driven Applications in Clinical Pharmacology and Translational S…
Brussels, 29 April 2025 – The ERAMET consortium is proud to announce the publication of a new article summarising the major achievements from its f…
On March 31st and April 1st, the ERAMET project held its second Face-to-Face Consortium Meeting, bringing together representatives from all partner…
The ERAMET project is transforming the development and approval of way drugs for rare and paediatric diseases. are developed and approved. With 30 …